Fingerprint
Dive into the research topics of 'Combined BRAF (dabrafenib) and MEK inhibition (trametinib) in patients with BRAFV600-mutant melanoma experiencing progression with single-agent BRAF inhibitor'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically